Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Brain Cancer – Market Insights, Epidemiology and Market Forecast – 2030” drug pipelines has been added to ResearchAndMarkets.com’s offering.
This report delivers an in-depth understanding of Brain Cancer, historical and f…
WILMINGTON, Mass.–(BUSINESS WIRE)–$CRL #bondoffering–Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it intends to offer $1 billion aggregate principal amount of senior notes due 2029 and 2031 (the “notes”) in an unre…
One vaccine, three routes for activating the entire immune system and providing T cell, B cell memory, and mucosal protection
The first COVID-19 vaccine trials designed to deliver both S and N SARS-CoV-2 viral proteins via multiple routes—subcutane…
One vaccine, three routes for activating the entire immune system and providing T cell, B cell memory, and mucosal protection
The first COVID-19 vaccine trials designed to deliver both S and N SARS-CoV-2 viral proteins via multiple routes—subcutane…
One vaccine, three routes for activating the entire immune system and providing T cell, B cell memory, and mucosal protection
The first COVID-19 vaccine trials designed to deliver both S and N SARS-CoV-2 viral proteins via multiple routes—subcutane…
One vaccine, three routes for activating the entire immune system and providing T cell, B cell memory, and mucosal protection
The first COVID-19 vaccine trials designed to deliver both S and N SARS-CoV-2 viral proteins via multiple routes—subcutane…
Agreement to perform fill/finish services for approximately 60–90 million doses in the U.S. this year
Manufacturing will take place at Baxter BioPharma Solutions’ Indiana facility
DEERFIELD, Ill., AND CAMBRIDGE, Mass..–(BUSINESS WIRE)–Baxter Int…
SAN DIEGO–(BUSINESS WIRE)–La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases, today announced …
SAN DIEGO–(BUSINESS WIRE)–La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases, today announced …
Additional company office in the Asia Pacific region will showcase Vetter’s expertise and help build and strengthen its business network in China
New office underscores importance of Chinese market
Physical presence promotes development of new bus…